Investigation of various methods for the cryopreservation of canine bone marrow-derived CD34+ cells

Journal of Veterinary Medical Science

Volumn 70, Issue 11, 2008, Pages 1211-1217

  Ide, Kaori ^a   Matsuura, Shinobu ^a   Fujino, Yasuhito ^a   Ohno, Koichi ^a   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone marrow; Canine; CD34+ cells; Cryopreservation; Hydroxyethyl starch

Indexed keywords

CD34 ANTIGEN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE MARROW CELL; CELL SEPARATION; CELL SURVIVAL; CRYOPRESERVATION; CYTOLOGY; DOG; FEMALE; MALE; METHODOLOGY; TIME;

ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CELL SEPARATION; CELL SURVIVAL; CRYOPRESERVATION; DOGS; FEMALE; MALE; TIME FACTORS;

BOVINAE; CANIS FAMILIARIS;

EID: 57349126304     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.70.1211     Document Type: Article

References (42)

1. Appelbaum, F. R., Deeg, H. J., Storb, R., Graham, T. C., Charrier, K. and Bensinger, W. 1986. Cure of malignant lymphoma in dogs with peripheral blood stem cell transplantation. Transplantation 42: 19-22.
2. Appelbaum, F. R., Deeg, H. J., Storb, R., Self, S., Graham, T. C., Sale, G. E. and Weiden, P. L. 1985. Marrow transplant studies in dogs with malignant lymphoma. Transplantation 39: 499-504.
3. Appelbaum, F. R., Herzig, G. P., Graw, R. G., Bull, M. I., Bowles, C., Gorin, N. C. and Deisseroth, A. B. 1978. Study of cell dose and storage time on engraftment of cryopreserved autologous bone marrow in a canine model. Transplantation 26: 245-248.
4. Bank, A. 2003. Hematopoietic stem cell gene therapy: selecting only the best. J. Clin. Invest. 112: 1478-1480.
5. Carlo-Stella, C., Cesana, C., Regazzi, E., Falzetti, F., Aversa, F., Rizzoli, V., Martelli, M. and Tabilio, A. 2000. Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor. Exp. Hematol. 28: 216-224.
6. + progenitor cell collection in patients with hematological malignancies. Am. J. Hematol. 58: 255-262.
7. David, N. A. 1972. The pharmacology of dimethyl sulfoxide. Annu. Rev. Pharmacol. 12: 353-374.
8. Deeg, H. J., Appelbaum, F. R., Weiden, P. L., Hackman, R. C., Graham, T. C. and Storb, R. C. 1985. Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation. Am. J. Vet. Res. 46: 2016-2018.
9. - cells expressing Flk2/Flt3. Br. J. Haematol. 119: 525-534.
10. Frimberger, A. E., Moore, A. S., Rassnick, K. M., Cotter, S. M., O'Sullivan, J. L. and Quesenberry, P. J. 2006. A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma. J. Vet. Intern. Med. 20: 355-364.
11. Fritsch, G., Emminger, W. Buchinger, P., Printz, D. and Gadner, H. 1991. CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp. Hematol. 19: 1079-1083.
12. Garrett, L. D., Thamm, D. H., Chun, R., Dudley, R. and Vail, D. M. 2002. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J. Vet. Intern. Med. 16: 704-709.
13. Gianni, A. M., Bregni, M., Siena, S., Brambilla, C., Nicola, M. Di., Lombardi, F., Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., Valagussa, P. and Bonadonna, G. 1997. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. New Engl. J. Med. 336: 1290-1297.
14. Goerner, M., Bruno, B., McSweeney, P. A., Buron, G., Storb, R. and Kiem, H. P. 1999. The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs. Blood 94: 2287-2292.
15. Goerner, M., Horn, P. A., Peterson, L., Kurre, P., Storb, R., Rasko, J. E. and Kiem, H. P. 2001. Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors. Blood 98: 2065-2070.
16. Gunji, Y., Nakamura, M., Osawa, H., Nagayoshi, K., Nakauchi, H., Miura, Y., Yanagisawa, M. and Suda, T. 1993. Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. Blood 82: 3283-3289.
17. Hacein-Bey-Abina, S., Fischer, A. and Cavazzana-Calvo, M. 2002. Gene therapy of X-linked severe combined immunodeficiency. Int. J. Hematol. 76: 295-298.
18. Haioun, C., Lepage, E., Gisselbrecht, C., Bastion, Y., Coiffier, B., Brice, P., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Gaulard, P. and Reyes, F. 1997. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin''s lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J. Clin. Oncol. 15: 1131-1137.
19. Horn, P. A., Keyser, K. A., Peterson, L. J., Neff, T., Thomasson, B. M., Thompson, J. and Kiem, H. P. 2004. Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. Blood 103: 3710-3716.
20. + cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transfusion 37: 1050-1057.
21. Katz, F. E., Tindle, R., Sutherland, D. R. and Greaves, M. F. 1985. Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk. Res. 9: 191-198.
22. Kiem, H. P., McSweeney, P. A., Bruno, B., Goerner, M., Buron, G., Morris, J., Storb, R. and Miller, A. D. 1999. Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector. Gene Ther. 6: 966-972.
23. Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C., Bhatia, M., Lapidot, T., Moritz, T., Murdoch, B., Xiao, X. L., Kato, I., Williams, D. A. and Dick, J. E. 1996. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2: 1329-1337.
24. Makino, S., Harada, M., Akashi, K., Taniguchi, S., Shibuya, T., Inaba, S. and Niho, Y. 1991. A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without rate-controlled freezing. Bone Marrow Transplant. 8: 239-244.
25. Matsuoka, S., Ebihara, Y., Xu, M., Ishii, T., Sugiyama, D., Yoshino, H., Ueda, T., Manabe, A., Tanaka, R., Ikeda, Y., Nakahata, T. and Tsuji, K. 2001. CD34 expression on long-term repopulating hematopoietic stem cells changes during developmental stages. Blood 97: 419-425.
26. McSweeney, P. A., Rouleau, K. A., Storb, R., Bolles, L., Wallace, P. M., Beauchamp, M., Krizanac-Bengez, L., Moore, P., Sale, G., Sandmaier, B., Revel, T. de., Appelbaum, F. R. and Nash, R. A. 1996. Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein. Blood 88: 1992-2003.
27. McSweeney, P. A., Rouleau, K. A., Wallace, P. M., Bruno, B., Andrews, R. G., Krizanac-Bengez, L., Sandmaier, B. M., Storb, R, E. Wayner, R. and Nash, R. A. 1998. Characterization of monoclonal antibodies that recognize canine CD34. Blood 91: 1977-1986.
28. Neff, T., Horn, P. A., Peterson, L. J., Thomasson, B. M., Thompson, J., Williams, D. A., Schmidt, M., Georges, G. E., Kalle, C. von. and Kiem, H. P. 2003. Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. J. Clin. Invest. 112: 1581-1588.
29. Okada, S., Nakauchi, H., Nagayoshi, K., Nishikawa, S., Miura, Y. and Suda, T. 1992. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 80: 3044-3050.
30. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J. Y., Harousseau, J. L. et al. 1995. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New Engl. J. Med. 333: 1540-1545.
31. Santini, G., Salvagno, L., Leoni, P., Chisesi, T., De Souza, C., Sertoli, M. R., Rubagotti, A., Congiu, A. M., Centurioni, R., Olivieri, A., Tedeschi, L., Vespignani, M., Nati, S., Soracco, M., Porcellini, A., Contu, A., Guarnaccia, C., Pescosta, N., Majolino, I., Spriano, M., Vimercati, R., Rossi, E., Zambaldi, G., Mangoni, L., Rizzoli, V. et al. 1998. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J. Clin. Oncol. 16: 2796-2802.
32. Sasnoor, L. M., Kale, V. P. and Limaye, L. S. 2003. Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells. J. Hematother. Stem. Cell Res. 12: 553-564.
33. Spangrude, G. J., Heimfeld, S. and Weissman, I. L. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
34. Spurr, E. E., Wiggins, N. E., Marsden, K. A., Lowenthal, R. M. and Ragg, S. J. 2002. Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage. Cryobiology 44: 210-217.
35. Stiff, P. J., DeRisi, M. F., Langleben, A., Gulati, S., Koester, A., Lanzotti, V. and Clarkson, B. D. 1983. Autologous bone marrow transplantation using unfractionated cells without rate-controlled freezing in hydroxyethyl starch and dimethyl sulfoxide. Ann. New York Acad. Sci. 411: 378-380.
36. Stiff, P. J., Koester, A. R., Weidner, M. K., Dvorak, K. and Fisher, R. I. 1987. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 70: 974-978.
37. Stiff, P. J., Murgo, A. J., Zaroulis, C. G., DeRisi, M. F. and Clarkson, B. D. 1983. Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch. Cryobiology 20: 17-24.
38. Takaue, Y., Abe, T., Kawano, Y., Suzue, T., Saito, S., Hirao, A., Sato, J., Makimoto, A., Kawahito, M., Watanabe, T. et al. 1994. Comparative analysis of engraftment after cryopreservation of peripheral blood stem cell autografts by controlled- versus uncontrolled-rate methods. Bone Marrow Transplant. 13: 801-804.
39. Thomasson, B., Peterson, L., Thompson, J., Goerner, M. and Kiem, H. P. 2003. Direct comparison of steady-state marrow, primed marrow, and mobilized peripheral blood for transduction of hematopoietic stem cells in dogs. Hum. Gene Ther. 14: 1683-1686.
40. Vail, D. M., MacEwen, E. G. and Young, K. M. 2001. Canine Lymphoma and Lymphoid Leukemias, pp. 558-590. In: (Kersey R. ed.), Small Animal Clinical Oncology, 3rd ed. W.B. Saunders, Philadelphia.
41. Weiden, P. L., Storb, R., Deeg, H. J. and Graham, T. C. 1979. Total body irradiation and autologous marrow transplantation as consolidation therapy for spontaneous canine lymphoma in remission. Exp. Hematol. 7 (Suppl. 5): 160-163.
42. Weiden, P. L., Storb, R., Deeg, H. J., Graham, T. C. and Thomas, E. D. 1979. Prolonged disease-free survival in dogs with lymphoma after total-body irradiation and autologous marrow transplantation consolidation of combination-chemotherapy-induced remissions. Blood 54: 1039-1049.